FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

Recruiting now · Phase 1/Phase 2

Conditions studied: Rhabdomyosarcoma

In brief

FaR-RMS is an over-arching study for children and adults with newly diagnosed and relapsed rhabdomyosarcoma (RMS)

Key facts

Study ID
NCT04625907
Run by
University of Birmingham
People needed
1672
Starts
2020-09-17
Expected to finish
2030-06-01
Last updated by the study team
2024-05-23

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.